Summary: The addition of a cerebral blood volume (CBV) compartment in the rI8FJ2-fluoro-2-deoxY-D-glu cose (FDG) model produces estimates of local CBV si multaneously with glucose metabolic rates when kinetic FDG studies are performed. We investigated the influ ence of this term upon CMRglc values in a series of brain tumor patients and found that significant overestimations of CMRglc are possible if the effect of CBV upon the model is ignored. The magnitude of this potential over estimation is directly related to the absolute value of CBV The [ 1 8 F]2-tluoro-2-deoxY-D-glucose (FDG) meth od for estimating CMRglc with positron emission tomography (PET) is now widely utilized in normal and pathologic states (Phelps et aI ., 1982). The model, originally developed for deoxyglucose (DG) by Sokoloff et al. (1977) , was modified by Phelps et al. [C�(t)J. this contribution was not included in the original Sokoloff model or in the Phelps and Huang modification because at the time of imaging (40 min after injection in a routine study) it is small com pared with C� and cZt. Additionally, in animal (i.e., rat) autoradiographic studies, the potential impact of intravascular activity is less than with human in vivo PET studies because the cerebral blood volume (CBV) in the decapitated animal is very small. However, in kinetic PET studies, the fraction of total tissue activity [C�(t)] in the vascular com partment is very high initially and neglecting its contribution can cause significant errors in the es timation of the model rate constants and calculated value of CMRglc. Initial kinetic studies by Phelps et al. (1979a) and Huang et al. (1980) minimized this problem by selecting regions for analysis that were at the more superior levels of the brain and distant from high blood volume territories. The CBV of the brain tends to decrease from inferior to superior sections and from lateral to medial. The exception to this is in the infero-medial territory of the venous
locally and inversely related to the CMRglc value. The kinetic estimates also permitted an evaluation of the FDG model in an environment with a variable disruption of the blood-brain barrier. Incorporating the vascular compart ment in the FDG model also frequently improved the sta tistical accuracy of model fits to tissue kinetic data. The sampling requirements for this model configuration were also investigated in a series of computer simulations. Key Words: Brain tumors-Cerebral blood volume-[18FJ2-Fluoro-2-deoxY-D-glucose.
[C�(t)J. this contribution was not included in the original Sokoloff model or in the Phelps and Huang modification because at the time of imaging (40 min after injection in a routine study) it is small com pared with C� and cZt. Additionally, in animal (i.e., rat) autoradiographic studies, the potential impact of intravascular activity is less than with human in vivo PET studies because the cerebral blood volume (CBV) in the decapitated animal is very small. However, in kinetic PET studies, the fraction of total tissue activity [C�(t)] in the vascular com partment is very high initially and neglecting its contribution can cause significant errors in the es timation of the model rate constants and calculated value of CMRglc. Initial kinetic studies by Phelps et al. (1979a) and Huang et al. (1980) minimized this problem by selecting regions for analysis that were at the more superior levels of the brain and distant from high blood volume territories. The CBV of the brain tends to decrease from inferior to superior sections and from lateral to medial. The exception to this is in the infero-medial territory of the venous sinuses and major branches of the internal carotid arteries. Carson et al. (1984) and Wienhard et al. (1985) demonstrated the potential of incorporating the vas cular component of FDG into the tracer kinetic model, but did not provide evidence of the accuracy of CBV estimated with this approach or the effect of the CBV term on the accuracy of the estimation of CMRglc.
The FDG operational equation requires appro priate average values of rate constants (k7 and k;
for forward and reverse capillary transport of FDG and k� and k: for phosphorylation and dephosphor ylation of FDG and FDG-6-P0 4 , respectively) (Eq. 2) for estimating CMRglc using a single measure ment of tissue I sF concentrations at late times after injection (i.e. , 40 min) . Alternatively, if the rate con stants for a given region are measured explicitly, CMRglc can be calculated without the operational equation if the plasma glucose (C p ) and lumped con stant (LC) are known (Eq. 4). Because evaluation of these rate constants requires tissue time-activity data [ c t(t)] generated from sequential images, the activity in the tissue vascular space will affect the ct(!) values, particularly in the early times after in jection. This can result in appreciably altered values of rate constants and of CMRglc. While theoretical and experimental studies on the effects of rate con stants on CMRglc values in pathologic states are available (Hawkins et aI. , 1981; Huang et aI. , 1981) , these investigations did not address the effect of CBV on the data.
We have included a CBV term in the FDG model as an adjustable parameter weighted by the shape of the plasma FDG clearance curve. This approach not only corrects for the vascular component of FDG and improves the estimates of the rate con stants and CMRglc, but also generates an estimate of CBV from the FDG data. We compared the CBV results obtained from the kinetic FDG studies with those measured directly with the [C 15 0]hemoglobin technique (Phelps et aI. , 1979b) . We have also ex amined the impact of this CBV correction upon es timated values of CMRglc in patient data and by computer simulation. Additionally, we employed a series of simulations to evaluate relevant temporal sampling issues in FDG kinetic studies, specifically scan durations, blood-sampling regimens, and timing errors (nonsimultaneity of image and blood data start times) . To examine this model under vari able conditions, studies were performed on patients with cerebral tumors. This provided normal and ab normal tissue regions with variable CBV, blood brain barrier (BBB) permeability, and CMRglc values.
METHODS AND MATERIALS

Patient popUlation
We studied 10 patients with primary or metastatic brain tumors. All subjects had 3-h kinetic FDG studies per formed; four had CBV studies performed with a single breath inhalation of C150. All subjects had x-ray com puted tomography examinations prior to their PET studies, which were used in selecting the optimum brain levels for the PET procedures.
FDG studies
Kinetic FDG studies were performed In a manner pre viously described (Phelps et aI., 1979a; Huang et aI., 1980) . Following the intravenous injection of 10 mCi FDG, images were obtained on a NeuroECAT tomograph (Hoffman et aI ., 1983 ) with a scan sequence consisting of 10 2-min scans, 10 5-min scans, and 10 IO-min scans for a total scan time of � 3 h. Immediately after injection, plasma FDG concentration measurements as a function of time [C;(t)] were obtained by sampling arterial blood from a radial intraarterial line. At later times in some subjects (i .e., at 210 min after injection when ISF plasma activity was slowly changing with time), samples were obtained from peripheral venous blood from the vein of a hand heated to 44°C to arterialize the blood (Phelps et aI ., 1979a) . In two subjects, the "hot venous" approach was used over the entire study. In all subjects, 2-ml sam ples were taken at 5-to IO-s intervals over the first 3 min and at progressively lengthening intervals for the duration of the study (Phelps et aI., 1979a) . Plasma counting was performed in a Nal well counter after centrifugation of the samples. Additionally, intermittent blood samples were obtained at regular intervals for determination of plasma glucose (C p ) and were found to be constant within ± 5% (standard deviation) throughout the studies.
C IS O studies
A modified version (using Cl50 rather than ilCO) of a method originally described by Phelps et al. (l979b) was used to generate estimates of CBV. Subjects inhaled 20-40 mCi CISO. Ninety-second images, obtained �2 min after inhalation, were used for quantifying CBY. The 2-min delay permits [CI50]hemoglobin to equilibrate in the blood pool. Blood samples (I m!) were obtained for whole-blood counting. If C( represents the activity con centration (counts/min/m\) of Cl50 in a given region of interest, Cb the blood concentration (counts/min/ml), and d the average density of brain tissue (1.04 g/ml, assumed to be equal in gray matter, white matter, and whole brain), then the local CBV (mIIlOO g) (LCBV) is
where the factor 0.85 corrects for the average difference in peripheral and central hematocrits and cal is the cali bration term between the tomograph and well counter (Phelps et aI ., 1979b) .
Mathematical model
Equations describing the model. The basic operational
where ® denotes the operation of convolution and
LCMRglc is the local CMRglc (f.lmol/minIlOO g or mg/ � in/l00 g); C p is the plasma glucose concent r ation; c7 (1) IS the cerebral concentration of free FDG (C E ) plus FDG-6-P0 4 (C�) at time T (obtained from region-of-interest image data); k�, k;, k�, and k: are the rate constants de fined above; C�(t) is the capillary plasma 18F time activity data as approximated by the arterial plasma val ues (input function); and LC is the lumped constant, de fined by
where 'A is the ratio of distribution volumes of FDG to glucose [k�/(k� + k�)]I[k/(k2 + k 3 )] when k: is small [quantities denoted with an asterisk ( * ) indicate terms related to FDG, while the same symbols without an as terisk are the corresponding terms for glucose]; V m and V; are maximum velocities, Km and K� are apparent Mi chaelis-Menten constants for glucose and FDG, respec tively, in the phosphorylation reaction catalyzed by hexo kinase; and <!> is the ratio of the net phosphorylation rate of glucose to the unidirectional rate of phosphorylation.
The term <!> has been shown to be quite close to 1.0 in normal and ischemic tissue states (Hawkins et aI., 1981) .
If the rate constants in a specific region are known, LCMRglc may be calculated directly from the relation ship (Huang et aI., 1980) values from region-of-interest data used in Eq. 5 are usu ally determined in relationship to mid scan times (t). How ever, the �can data actually represent the average value of Cf(t) [Cf(t) ] over each scan interval, that is, (6) t:.T where T, and T2 are the scan start and end times, re spectively, and t:.T = T2 -Tj is the scan duration. To derive an analytical expression for fCf(t)dt in terms of measurable quantities and unknown parameters, one be gins with the following equation for the rates of change f * * o Ct(t) and C M (t) based upon the three-compartment
From Eqs. 7 and 8 it follows that
where T] and T2 are scan start and end times, tively.
Adding Eqs. 9 and 10 and rearranging terms yields From Eqs. 12, 13, and 11,
Incorporation of vascular compartment in FDG model. Each measured value of C7{t) actually includes a tissue vascular component, even though it has been assumed to be zero in previous models for DG and FDG. Therefore, the term CBV J�1C;(t)dt must be added to Eq. 14, where CBV represents the FDG vascular space volume of tissue. Because FDG rapidly equilibrates with red blood cells in humans (Phelps et aI., 1979a ) (although not in rats), this term represents CBV (% vol or mill 00 g). Rear ranging terms of Eq. 14 and incorporating the vascular volume term yields where C j(t) is defined by Eq. 5 and C lI(t) is given by (Phelps et aI., 1979a; Huang et aI., 1980) (16) where (X] and (X2 are defined above with Eq. 2.
Equation 15 is the relationship used for determining the rate constants (k7, k;, k�, k!) and the kinetically deter mined value of CBV from the FDG study. The simulation studies discussed below also employed this equation in the parameter estimation process.
Method for estimating LC. Several approaches exist for evaluating the numerical value or the stability of LC. Direct measurement of the steady-state arteriovenous dif ferences of FDG (or DG) to glucose (Sokoloff et aI., 1977) produces a global estimate of LC. All other methods involve significant assumptions about the relative magni tude of some variables that are not easily measured in humans (e.g., the relative magnitude of Michaelis Menten parameters for glucose and FDG, transport af finity constants for glucose, etc.), but do provide ap proaches for assessing local stability or variations in LC. Phelps et ai. (1983) demonstrated an approach for es timating the stability (although not the absolute value) of the local LC in vivo. LC may be expressed in terms of the individual rate constants as follows: (17) Since <p is expected to be very close to 1.0 and very insensitive to changes in the glucose/glucose-6-P04 ratio (Hawkins et aI., 1981) , using values for the ratios k�/kj (i = 1,2,3) obtained from the literature yields (Phelps et aI., 1983 ) (18) Therefore, an evaluation of k�/k; on a local basis will be an index of the relative stability of LC.
Gjedde and Diemer (1983) described an approach for measuring brain glucose content with 3-0-methylglucose autoradiography in rats. Because the value of LC is closely related to the brain glucose content (Crane et aI., 1981; Gjedde, 1982; Pard ridge et aI., 1982) , a similar ap proach in humans with PET could also yield insights into local LC stability. However, because the ratio k/k 2 (for ward versus reverse transport across the BBB defined by k7lk; for FDG) should be constant for all hexoses (Gjedde, 1982) , local kinetic data obtained with FDG will yield qualitatively similar information regarding local LC sta bility as the local concentration of a nonmetabolizable glucose analog such as methylglucose that has a distri bution volume of k/k2• (15)
RESULTS AND DISCUSSION
Simulations
We performed a series of computer simulations to investigate two general issues relevant to the five-parameter FDG model. The first concerned sampling requirements necessary for accurate pa rameter estimation. These included three areas: scan duration, frequency of blood sampling, and timing errors (nonsimultaneity of scan and blood data start times) . The second set of simulations dealt with the impact of the vascular term upon the estimated values of the rate constants and CMRglc determined by the FDG method.
Blood sampling. As described in Methods and Materials, we normally acquire plasma I S F samples at 5-to lO-s intervals over the first 3 min of a study when plasma activity is changing most rapidly. Figure 1 is an example of a typical input function from one patient study with a bolus injection. To determine the instantaneous values of C�(t), the input function was approximated by a linear equa tion from time 0 until the peak value and with a three-exponential curve thereafter. Using a set of rate constants and CBV value generated with the five-parameter model from one patient region (k7 = 0.027 ml/min/g, k� = 0.071 min-I, kj = 0.034 min -1, k'S = 0.0091 min -1, CBV = 6.4 ml/100 g) ,
we generated Ci(t) values over a set of scan in tervals using the same scanning sequence employed for patient studies (10 2-min scans, lOS-min scans, and 10 10-min scans) . We then estimated sets of rate constants and CBV estimates using Eq. 15 and nonlinear regression. In the regression, the blood sampling interval was varied from 1 to 30 s over the first 3 min of the study. After 3 min the original sampling sequence was employed. Figure 2 illus trates the results of this simulation. There is clearly very little effect upon the generated values of kj-k'S and CBV with initial sampling intervals up to 10 s, confirming the validity of our experimental blood sampling protocol. Scan duration. The effect of the length of the initial scans upon parameter values was evaluated by generating c7ct) tissue data based upon a stan dard set of rate constants, adding statistical noise, and then fitting the data with Eq. 15 , again using a standard (real) input function. The simulated scan Filled circles are data points and the smooth line represents a linear fit from time 0 to the peak value and a three-expo nential fit thereafter. Arterial blood was sampled from the radial artery for the entire 3-h study in this case, although in some patient studies hot venous sampling replaced arterial sampling 10-30 min after the injection. times ranged from 12 s to 3.5 min over the first 4 min of the study. A typical scan sequence described in Methods and Materials was used for the re mainder of the study (4-180 min) . Selected examples of the effect of initial scan time on parameter estimation. These are representative simulated tissue curves for 12-s initial scans, 30-s scans, 1-min scans, and 2-min scans. Note that the "vascular peak" is evident with the 12-s initial scans but is progressively less evident on longer scans as it is averaged with the tissue data. Sta tistical noise was added to the simulated data points (filled circles). Smooth lines connecting the data points are the model fit to the data.
noise) and the smooth line is the model fit to the data. There is a visible "vascular peak" in the 12-s scan data that is progressively reduced in the longer scans and finally is no longer apparent in �2-min scans. This reflects the averaging effect of longer initial scans upon the initial vascular phase activity. Figure 4 illustrates the average value of the estimated parameter as a function of the initial scan time. These values remain quite close to the ex pected values over the entire range of initial scan times. However, Figure 5 illustrates that the coef ficient of variation of the individual parameters (only the CBV term is illustrated) does increase with longer initial scan times, but changes only relatively slightly with scan intervals ranging from 12 s (coef ficient of variation � 1 %) to 2 min (�2%). This in dicates that initial scan intervals of from 30 s to 2 min in duration, as we normally employ in our FDG patient kinetic studies, permit accurate estimation of FDG parameters in the range of values consid ered.
As an alternative to the 2-min initial scans nor mally employed in our human FDG kinetic studies, we performed one study in which the scan projec tion data as a function of time were obtained as described by Huang et al. (1982, 198 3) for blood flow measurements with [ 15 0] H 2 0. The projection measurement as a function of time provides a closely sampled tissue curve over the first 8 min of the study, while a typical scanning method and se quence as described above were used for the re mainder of the study. Figure 6 illustrates the results of this approach in a normal volunteer. While the four-parameter FDG model did not converge to a Plot of coefficient of variation (defined as the esti mated parameter standard error divided by the parameter value) for cerebral blood volume term using data of simula tion results illustrated in Fig. 4 . Note that while the coefficient of variation is smallest for the shortest (12 s) initial scans (�1%), it increases only slightly (to �2%) with 2-min initial scans.
unique solution of the rate constants for these data, the five-parameter model described in this work yielded rate constants kr, k;, and k� typical of normal hemispheric tissue (k: was fixed because of the total duration of the study was � 1 h) , while the kinetically determined CBV was 4.5 ml/IOO g.
Timing errors. Nonsimultaneity in the start times of image [Cf(t)] and blood [C;(t)] data occurs fre quently because of technical and physiologic rea sons. The tomographic and blood sampling regi mens are normally initiated manually and therefore involve two separate timers. Therefore, a delay in starting one of these devices could introduce such a timing error. Additionally, blood samples obtained from a peripheral artery or vein may have a some what different transit time from the site of injection than to the cerebral capillary bed. We performed a series of simulations analogous to those above with differing initial scan times and differing magnitudes of timing errors superimposed upon the data. Fig  ures 7 and 8 illustrate the effect of a 6-s delay in the input function relative to the tomograph as a func tion of initial scan length. While the generated pa rameters do remain fairly close to expected values (Fig. 7) , the coefficient of variation increases sig nificantly for all parameters at short scan times (Fig. 8) . With larger timing errors (Fig. 9) rameter model rate constants divided by the same term evaluated with four-parameter model rate con stants yields an estimate of the ratio of metabolic rates determined with the two models. This ratio is defined as the metabolic ratio (MR). Therefore, if the same set of tissue data points are fitted with both a four-and five-parameter FDG model (Eq. 15 for the five-parameter model and the same equation without the vascular term for the four-parameter model) , then MR is _ kj* kj*/(k�* + k�*) MR = ki*kj*/(k�* + kj*) (19) where the superscripts 4 and 5 refer to the four-and five-parameter model fits, respectively. For these simulations, Cr(t) was generated for given sets of rate constants and CBV values while Ci(t) was as described as above. The generated C i(t) values were then fitted by the four-parameter model (Eq. 15 with CBV equal to zero). MRs (Eq. 19) as a func-FIG. 8. Coefficients of variation (CV) as a function of initial scan time with a 6-s timing error for the data plotted in Fig. 6 . Note that the CV values for all parameters increase significantly for shorter initial scans (i. e., <0. 8 min). tion of CBV were then cakuiated. Figures 10 and 11 illustrate the results of these simulations with CBV values from 0 to 10 mll lOO g. In Fig. 10 , the simulated tissue data sets were generated with rate constants obtained from gray matter with a normal CMRglc value, while in Fig. 11 rate constants from a region with a low CMRglc value were used. It is evident from these figures that in the normal met abolic range (Fig. 10 ) data, the MR decreases by <10% over the range of CBV values tested, indi cating a < 10% overestimation of CMRglc if the four-parameter, rather than five-parameter, model is employed. However, with the hypometabolic data ( Fig. 11) , the MR decreases by �40% over the Metabolic ratio (MR) (defined by Eq. 19) vs. cerebral blood volume (CBV) using rate constants from a gray matter region with CMRglc = 21 fJ-mol/min/100 g. Note that while the MR decreases as CBV increases from 0 to 10 ml/100 g, this decrease is <10% over the range of CBV values esti mated, indicating a <10% potential overestimation of CMRglc with the four-parameter model, an error probably within the routinely achievable experimental accuracy of the procedure. same range of CBV, indicating a potential 67% over estimation of CMRglc with the four-parameter com pared with the five-parameter approach with a CBV of 10 mlllOO g. While a range of CBV up to 10 mIl 100 g may seem high for normal tissue regions, rel ative CBV values can approach 100% in brain re gions including large vascular structures. Addition ally, in pathologic states (e.g. , tumors) , the regional CBV may also be increased. These simulations do not employ the operational equation in calculating CMRglc, and a similar analysis of actual patient data using both the MR and operational equation approach is included below.
L..--+---+----+---+---t----+---+----+--
Patient studies
CBV estimates and rate constants. As discussed above, the addition of the fifth parameter to the FDG model permits the determination of CBV from the FDG kinetics. In this series, eight subjects were studied who had true arterial blood samples at early times that were later converted to arterialized ve nous sampling, and two had arterialized venous sampling from the beginning of the study. Ta ble 1 summarizes the results of the CBV values in these two patient groups, while Ta ble 2 lists the values of the four-and five-parameter fits in the arterial sam pling group. In each patient, regions of interest in cluded representative gray matter regions, white matter regions, tumor areas, and hemispheres. While the CBV estimates in the arterial sampling group are in the physiologic range, those from the group with blood sampled from a heated hand are higher than expected. Even though all patients in this series had tumors and had undergone a variety (Phelps et aI. , 1979a) and produce such an overestimation in CBY. In four subjects from the arterial sampling group who had direct measurements of CBV with inhaled C I5 0 immediately before the FDG study, the ratio of CBV determined kinetically with FDG to that measured directly with C I5 0 in aII regions was 0.79 ± 0.62 (average ± SD) . The amount of CO inhaled as C I5 0 is too small to have any direct physiological effect on cerebral blood flow (i.e., the tracer con dition applies) . While this ratio is not significantly different from 1.0 (p > 0.05), individual variation accounted for the relatively large standard de- (Hawkins et aI. , 1984) . As discussed in that work, methodological issues could impact upon the mea surements of CBV with C 15 0, including errors in blood counting because of the short half-life (2 min) of 15 0. Nevertheless, the kinetically determined es timates of CBV obtained in this study in the arterial sampling group are in the physiologic range and agree well with prior studies directly measuring CBV (Phelps et aI. , 1979b) .
Ta ble 2 illustrates that the addition of the CBV term results in a significant decrease (five-param eter model compared with four parameters) in kr and k;, less of a change in k�, and little change in k!. The relative changes in the rate constants for the four-and five-parameter model configurations are larger than reported by Carson et ai. (1984) in normal patients. It should be remembered, how ever, that these rate constants were derived from a population of abnormal patients (e.g. , many of the apparently "normal" gray, white, and hemispheric regions had undergone radiation therapy) . There fore, the magnitude of the rate constants and their relative differences in the four-and five-parameter model configurations are specific to this patient population. Further studies employing the methods of this investigation in normal subjects are pro ceeding.
CMRglc values: results with tour-and five-pa rameter models. Glucose metabolic rates can be generated with Eqs. 2 and 4 with the four-or five parameter models and the appropriate sets of rate constants. The simulation studies above show that there is a potential overestimation of CMRglc with the four-parameter model that could be more sig nificant in hypometabolic regions. In those subjects who had arterial sampling initially, we analyzed the MRs (Eq. 19) and also the CMRglc ratios (defined by dividing CMRglc values obtained with Eq. 2 de termined with rate constants generated by the five parameter approach by CMRglc values determined with the four-parameter model) . These calculations were performed regionally over representative tumor, gray, white, and hemispheric regions in each patient and then averaged to generate values of the two ratios in the four types of regions in each pa tient. Figure 12 is a plot of these two ratios in that patient group. The two ratios are well correlated; linear regression analysis yielded a correlation coef ficient of 0.94 and a slope of l.03 . This is consistent with previous results reported by Phelps et at. (1979a) and Huang et ai. (1980) where in normal volunteers both Eqs. 2 and 4 yielded very similar CMRglc values. It also implies that any overesti mation of CMRglc resulting from the four-param eter model and Eq. 4 (i.e. , as in Simulations) would also be present using the operational equation (Eq. 2) . A plot of the CMRglc ratio versus CBV (deter mined kinetically) is illustrated in Fig. 13 . While there is significant scatter in the data, many of the regional groups are characterized by a significant overestimation in CMRglc with the four parameters compared with the five-parameter model (i.e., CMRglc ratio < 1.0). This overestimate ranges up to -60% , in good agreement with the magnitudes predicted in the simulation studies above. It is also evident from Fig. 13 that many of the tissue regions had CMRglc ratios near unity. Some patients had relatively normal CMRglc values in many regions of the brain, while others had widespread hypo metabolic zones. Because brain tumors are known to produce hypo metabolic effects remote from their anatomic origin and other factors such as cerebral edema can produce similar effects, such heteroge neity in tissue metabolism is not surprising. Addi tionally, while the FDG operational equation is known to be relatively insensitive to the exact values of the rate constants, the close correspon dence of the MR and CMRglc ratio (Fig. 12 ) indi cates that with either the operational equation or the local rate constant approach, there is a potential overestimation of CMRglc with a four-parameter model. Figure 14 is a plot of the CMRglc ratio versus the ratio of CBV to CMRglc in the same data group. While many of the data points are clustered near a CMRglc ratio of 1.0 , there is a trend for this ratio :::;: to decrease as the CBV /CMRglc ratio increases. Thus, the higher CBV is relative to CMRglc, the more significant the overestimation of CMRglc is with the four-parameter model. However, in those regions with a CBV /CMRglc ratio approximating that of normal hemispheric values (i. e. , for a CBV of 5 mll lOO g and CMRglc of 30 J.,Lmolimin/ lOO g, this ratio is 0.17 mliJ.,Lmol/min) , the CMRglc ratio is near unity, suggesting that in normal brain or in re gions without very high LCBV values both the four- and the five-parameter model will yield similar CMRglc estimates, although some overestimation of CMRglc with the four-parameter model is still expected. Statistical comparison of four-and Jive-param eter models. A variety of statistical methods exist to test among alternative models for their adequacy in describing experimental data. Conceptually, these methods help to identify the most efficient model configuration, that is, the model with the fewest number of parameters that accurately fit the data (Landaw and DiStefano, 1984) . Because regression routines involve minimizing the residual sum of squares (RSS) (the sum of the squared dif ferences between experimental data and a set of model-predicted values) , adding a parameter to a model will often decrease the RSS even if it does not fit the data significantly better. Specifically, a decrease in RSS may not be statistically significant. Three such methods for distinguishing between al ternative models with differing numbers of param eters are a method involving the F statistic, the Akaike information criterion (AIC) (Akaike, 1974) , and the Schwarz criterion (Schwarz, 1978) . The F statistic is computed from the following equation:
where RSS I and RSS2 refer to the residual sum of squares for the lower (in this work the four-param eter) and higher (five-parameter) models, respec tively; p] and P2 are the number of parameters in the alternative configurations (four and five); and N is the number of data points (30 in this work) . This F statistic has (P2 -P I ' N -Pz) degrees of freedom. A p value less than an acceptable limit (e.g., 0.05) rejects the null hypothesis that the lower-order (four-parameter) model is correct and supports the five-parameter configuration. Alter natively the Akaike information and Schwarz cri terion also generate a numerical description of the adequacy of the model using values of RSS, num bers of parameters, and data points and lead to a "score." The model configuration with the lowest score is preferred. Landaw and DiStefano (1984) recommend using all three of the above approaches in the same data set as they generally should yield consistent results. (Genesio and Milanese, 1979) , which indicated that the difference in the above Akaike information criterion values is highly significant. The small p value and the relatively lower Akaike information and Schwartz criteria values for the five-parameter model all indicate that it is the preferred configuration. Figure 15 is an example of these approaches ap plied to an actual region of interest data set in this study. In that example, the five-parameter model visually approximated the data set more closely than the four-parameter model. Additionally, the F statistic, and the Akaike information and Schwarz criterion all supported the five-parameter as op posed to the four-parameter model. This result was typical of our experience in many other regions in this group of patients. In some regions neither the four-nor the five-parameter model fit the data well, and in some regions one configuration yielded an adequate convergence while the other did not. Non convergence probably resulted from patient motion adding additional noise to the data.
In addition to such statistical comparisons, how ever, the choice of a model configuration often must be made on physiologic grounds (Carson et aI. , 1983) , even without a statistical difference or im provement in the fits. Because the five-parameter FDG model yields additional information about the local vascular status (i.e. , CBV) and can decrease overestimations in LCMRglc, it offers potential ad vantages over the four-parameter model indepen dently of fitting accuracy issues.
Compartmental configuration and LC stability. Two important issues related to the application of the FDG method in pathological states include the compartmental configuration of the model and the stability of LC. While the conceptual significance of the effect of CBV on CMRglc estimates and the sampling issues discussed above would be little af fected even with a changing LC, the absolute value of CMRglc is inversely proportional to the value of LC (Eqs. 2 and 4). Additionally, the compartmental configuration of the FDG model presupposes that the transport and phosphorylation processes may still be described by the four rate constants (kr, k;, k;, and k:) even with partial disruption of the BBB.
The stability of LC may be evaluated locally from the FDG kinetic data using Eq. 18. Crane et al. (1981 ), Pard ridge (1983 , Gjedde (1982), and Petti grew et al. (1983) have shown (under the assump tions of their models) that the local value of LC is expected to be a function of tissue glucose concen trations. That is, a transport-limited state charac terized by low cerebral blood flow and a nonzero CMRglc could result in low tissue glucose concen trations and an elevated value of LC. Estimating the local tissue glucose concentration therefore could yield insight into the potential variability in LC . Gjedde and Diemer (1983) reported such a method utilizing 3-0-methylglucose in rat autora diographic brain studies. They found no significant regional differences in tissue glucose concentra tions in normal rat brain and concluded that LC probably did not vary significantly from region to region in normal states in rats.
As pointed out by Gjedde (1982) , the ratio k/k2 (forward and reverse transport rate constants for hexose transport across the BBB) should be the same for all hexoses. Therefore, the ratio krlk; mea sured for FDG should yield qualitatively similar in formation as the regional distribution of 3-0-meth ylglucose. Alternatively, as shown by Phelps et al. (1983) , the value of k;lk; (Eq. 18) can also be used as an index of the variability of LC. Table 3 contains a summary of the krlk; and k;lk; ratios using the five-parameter model in the arterial sampling group in tumor, gray, white, and hemispheric regions.
While the krlk; value is somewhat higher in gray matter than other regions, the difference was not statistically significant (p > 0.05) and the k;lk;
values were quite similar in all four region types. Therefore, there appeared to be no systematic vari ation in LC in this heterogeneous group of patients and tissues. Additionally, the same ratios did not differ significantly between regions for each indi vidual subject.
A disruption in the BBB could alter the kinetics of FDG transport and potentially impact upon the model configuration. DiChiro et al. (1984) discussed this issue and the LC in relation to their studies on human brain tumors with PET. Citing autoradio graphic evidence of the independence of DG uptake and BBB disruption (Blasberg et al. , 1981) in animal glioma models and their own clinical experience in humans, they concluded that BBB disruption is un likely to affect the model significantly. They also concluded that LC probably was not changing sig nificantly in their tumor patients who were not char acterized by transport-limited ischemic states. These conclusions are consistent with our results.
A disrupted BBB could increase kr and k; by ap parently increasing the free diffusion of FDG across the BBB. The normalized ratios of kr and k; (the ratio of kr and k; in tumor, gray, and white tissue to corresponding hemispheric values) were 0.83 Hawkins et al. (1984) , the kr and k; normalized ratios were not significantly different from those cited above, even though a definite BBB abnormality (characterized by marked [ 68 Ga] EDTA uptake and a EDTA transfer constant of 0.0049 mllmin/g) was evident. This suggests that even with mechanical or diffu sion BBB abnormalities, the dominant mechanism of glucose transport probably remains facilitated diffusion and that the original compartment struc ture is still appropriate.
CONCLUSION
The results of this study indicate that including CBV in the FDG model can have a significant im pact on the estimated CMRglc values, particularly if the CBV /CMRglc ratio is elevated above the normal range.
The sampling requirements for the five-parameter approach are easily met with standard tomographic protocols (including arterial sampling) within rea sonable ranges of CBV and CM Rglc, and the method generates local values of CBV that are in the physiologic range. As demonstrated in previous studies, the FDG model configuration and prede termined standard values of LC appear to be ap propriate in this group of tumor patients. The ad ditional parameter in the model yields information about the tissue vascular status (i.e., CBV) .
The five-parameter model frequently produced statistically better fits than the four-parameter model ( Fig. 15 ) with a typical scan sequence. With very short initial scans, the four-parameter model may not even converge to a solution (Fig. 6 ) . There fore, it appears that a five-parameter FDG model is generally preferable to the four-parameter model on both statistical and biological grounds.
